Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed.

In 1972 a nonsocomial outbreak of parenterally transmitted hepatitis affected both marrow transplant patients and normal platelet donors in an oncology unit. Because of the characteristics of the clinical illness, the incubation period of 27 days, and the effect of immune serum globulin on the clinical illness, the outbreak was attributed to hepatitis A; there was no serologic evidence of either hepatitis B virus or cytomegalovirus infection. Stored serums from this outbreak were re-examined by more recently developed serologic techniques for evidence of hepatitis A (HA) virus infection. Ten patients and donors had undetectable anti-HA titers before illness and none seroconverted; five persons had pre-existent anti-HA titers and showed no further rise in convalescent serums. The serum of one patient was inevaluable. With the availability of serologic techniques for the diagnosis of both hepatitis A and hepatitis B virus infections, it is clear that most cases of post-transfusion hepatitis are not due to either of these agents, and short-incubation-period hepatitis can not be assumed to be hepatitis A without further investigation.

[1]  R. Purcell,et al.  Multiple Hepatitis Viruses in Multiple Attacks of Acute Viral Hepatitis , 1977 .

[2]  R. Purcell,et al.  Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination , 1976, Infection and immunity.

[3]  M. Hilleman,et al.  Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. , 1975, The New England journal of medicine.

[4]  P. Feorino,et al.  HBsAg negative hepatitis in a hemodialysis unit. Relation to Epstein Barr virus , 1975 .

[5]  R. Knodell,et al.  Etiological spectrum of post-transfusion hepatitis. , 1975, Gastroenterology.

[6]  R. Purcell,et al.  CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS , 1975, The Lancet.

[7]  S. Krugman,et al.  Viral hepatitis, type A: identification by specific complement fixation and immune adherence tests. , 1975, Transactions of the Association of American Physicians.

[8]  G. Grady,et al.  Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. , 1974, Lancet.

[9]  K. Holmes,et al.  Parenterally transmitted hepatitis A associated with platelet transfusions. Epidemiologic study of an outbreak in a marrow transplantation center. , 1974, Annals of internal medicine.

[10]  R. Purcell,et al.  Hepatitis A: Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute Illness , 1973, Science.

[11]  J. Roche,et al.  Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis. , 1973, The New England journal of medicine.

[12]  R. Purcell,et al.  Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. , 1972, Annals of internal medicine.

[13]  D. Gocke A prospective study of posttransfusion hepatitis. The role of Australia Antigen. , 1972, JAMA.

[14]  W. Henle,et al.  Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines. , 1971, Journal of the National Cancer Institute.

[15]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.